| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.2M | +1357.8% |
| R&D Expense | $105.6M | +31.5% |
| SG&A Expense | $30.7M | +41.5% |
| Operating Income | -$117.1M | -16.3% |
| Net Income | -$108.9M | -7.5% |
| EPS (Basic) | -$2.62 | +4.0% |
| EPS (Diluted) | -$2.62 | +4.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.2M | -48.4% |
| Current Assets | $351.4M | -23.5% |
| Total Assets | $404.9M | -22.1% |
| Current Liabilities | $55.2M | +13.4% |
| Total Liabilities | $404.8M | -4.3% |
| Stockholders' Equity | $112K | -99.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $193.6M | +485.3% |
| Capital Expenditures | $1.2M | -63.5% |
| Investing Cash Flow | -$244.3M | -775.4% |
| Financing Cash Flow | $1.8M | -92.1% |
| Free Cash Flow | $192.4M | +459.2% |